Lonza: latest news - GoINPHARMA
Saturday, 15 December 2018 - 22:32


Lonza opens new research center in Israel

Switzerland-based Lonza, a leader in life sciences, has opened today its R&D center in Israel, named Israeli Collaborative Innovation Center (CIC), located in Haifa’s Life Science Park. The center currently employs 15 researchers, focusing on molecular biology and molecular genetics….

Lonza to acquire Capsugel for $5.5bn

Lonza Group AG acquired US-based Capsugel S.A. from KKR fund for $5.5bn in cash, including debt ($2bn), corresponding to a 15.1x EBITDA multiple. The Basel, Switzerland-based group stated it expects to achieve operating synergies of approximately CHF30m pa, as well…

Lonza close to deal to acquire Capsugel

Switzerland-based group Lonza is now close to acquire Capsugel, the same Lonza confirmed today in a brief press release, adding it has a strong interest in the US-based (New Jersey) company, owned by private-equity KKR & Co. According to experts,…

Lonza to divest peptides business to PolyPeptide

Lonza divested nearly all of its peptides business to Sweden-based PolyPeptide. The Braine-l’Alleud facility, Belgium, employing a workforce of 280 and developing and producing new peptides, is part of the transaction. Lonza acquired the site from UCB in 2006. The…